Related Experiment Video
Updated: May 3, 2026

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
Published on: May 3, 2018
Ethnic Disparities in Cardiovascular Disease: A Comparative Analysis of Asian and Central Asian Populations
Syed Azfar Hossain1, Fakher Rahim2, Zhyparkul Derbishalieva3
1Department of Introduction to Internal Medicine and Family Medicine, International Higher School of Medicine, 1F, Intergelpo St, 720054, Bishkek, Kyrgyzstan. hossainsyedazfar@icloud.com.
Background:
Cardiovascular diseases (CVD) are the leading cause of death globally, with a significant burden on the Asian and Central Asian populations. Ethnic discrimination is an emerging determinant of CVD risk, yet comprehensive analyses in these populations are sparse.
Objectives:
This systematic review aimed to assess the association between ethnic discrimination and CVD among Asian and Central Asian populations, quantifying risks and examining contributing factors.
Methods:
Following the PRISMA guidelines, we reviewed 23 studies across PubMed, Scopus, and the Web of Science, including 10 on Central Asian and 13 on broader Asian populations. Risk measures such as odds ratios (ORs) and hazard ratios (HRs) were extracted where available.
Results:
The findings indicate a robust association between ethnic discrimination and increased CVD risks. Among Kyrgyz and Kazakh populations, discrimination was linked to hypertension with an OR of 2.4, while ethnic Kazakhs experiencing discrimination had a 70% higher risk of all-cause mortality (HR 1.7). In South Asians, discrimination was associated with a 30% higher prevalence of premature cardiovascular events, while Chinese populations exposed to everyday discrimination demonstrated a 15.2% higher prevalence of hypertension. Rural populations in Central Asia showed clustering of CVD risk factors with an OR of 1.9.
Conclusions:
Discrimination is a significant contributor to CVD disparities, with its effects varying across ethnic groups and regions. These findings underscore the need for culturally tailored public health interventions and policies addressing social determinants of health. Future research should explore longitudinal impacts and the efficacy of targeted community-based programs to mitigate these risks.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...

